These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27547842)

  • 21. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vibrating membrane devices deliver aerosols more efficient than standard devices: a study in a neonatal upper airway model.
    Tiemersma S; Minocchieri S; van Lingen RA; Nelle M; Devadason SG
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):280-6. PubMed ID: 23273244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Approach Methodology for Assessing Inhalation Risks of a Contact Respiratory Cytotoxicant: Computational Fluid Dynamics-Based Aerosol Dosimetry Modeling for Cross-Species and In Vitro Comparisons.
    Corley RA; Kuprat AP; Suffield SR; Kabilan S; Hinderliter PM; Yugulis K; Ramanarayanan TS
    Toxicol Sci; 2021 Aug; 182(2):243-259. PubMed ID: 34077545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oropharyngeal deposition of 3.5 microns particles inhaled through an elongated mouthpiece.
    Svartengren K; Anderson M; Svartengren M; Philipson K; Camner P
    Eur Respir J; 1996 Jul; 9(7):1556-9. PubMed ID: 8836672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Soft Mist Inhaler Aerosol Velocity, Size, and Deposition Inside the Mouth-A Computational Fluid Dynamics Study.
    Sadeghi T; Pakzad L; Fatehi P
    J Biomech Eng; 2023 Jun; 145(6):. PubMed ID: 36826406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Evaluation of a Family of Human Face and Upper Airway Models for the Laboratory Testing of Orally Inhaled Products.
    Nagel MW; Suggett JA; Coppolo DP; Mitchell JP
    AAPS PharmSciTech; 2017 Nov; 18(8):3182-3197. PubMed ID: 28536796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations.
    Zeman KL; Wu J; Bennett WD
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):363-9. PubMed ID: 20863250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of gender and device mouthpiece shape on bolus insulin aerosol delivery using the AERx pulmonary delivery system.
    Boyd B; Noymer P; Liu K; Okikawa J; Hasegawa D; Warren S; Taylor G; Ferguson E; Schuster J; Farr S; Gonda I
    Pharm Res; 2004 Oct; 21(10):1776-82. PubMed ID: 15553222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerosol Therapy in Adults Receiving High Flow Nasal Cannula Oxygen Therapy.
    Réminiac F; Vecellio L; Heuzé-Vourc'h N; Petitcollin A; Respaud R; Cabrera M; Pennec DL; Diot P; Ehrmann S
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):134-41. PubMed ID: 26196740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
    O'Riordan TG; Amram JC
    J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suitability of the upper airway models obtained from MRI studies in simulating drug lung deposition from inhalers.
    Ehtezazi T; Southern KW; Allanson D; Jenkinson I; O'Callaghan C
    Pharm Res; 2005 Jan; 22(1):166-70. PubMed ID: 15771244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of in vitro deposition of pharmaceutical aerosols in an idealized child throat with in vivo deposition in the upper respiratory tract of children.
    Ruzycki CA; Golshahi L; Vehring R; Finlay WH
    Pharm Res; 2014 Jun; 31(6):1525-35. PubMed ID: 24395403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition.
    Sagalla RB; Smaldone GC
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):341-8. PubMed ID: 25105472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosolized drug delivery: fractional deposition of inhaled particles.
    Bennett WD
    J Aerosol Med; 1991; 4(3):223-7. PubMed ID: 10147680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose delivery late in the breath can increase dry powder aerosol penetration into the lungs.
    Bondesson E; Bengtsson T; Borgström L; Nilsson LE; Norrgren K; Olsson B; Svensson M; Wollmer P
    J Aerosol Med; 2005; 18(1):23-33. PubMed ID: 15741771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro-in vivo correlations (IVIVCs) of deposition for drugs given by oral inhalation.
    Newman SP; Chan HK
    Adv Drug Deliv Rev; 2020 Dec; 167():135-147. PubMed ID: 32593641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery.
    Martin AR; Moore CP; Finlay WH
    Expert Opin Drug Deliv; 2018 Dec; 15(12):1175-1188. PubMed ID: 30388902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.